Vulvovaginal Candidiasis Completed Phase 3 Trials for Natamycin (DB00826)
Also known as: Vulvovaginal Candidiases / Vulvovaginal Candidiasis, Genital / Vulvovaginal Candidiasis (VVC) / Candidiasis, Vulvovaginal / Vulvo-vaginal Candidiasis / Acute candidiasis of vulva and vagina / Candidiasis of vulva and vagina / Candidal vulvovaginitis (disorder) / Vulvovaginal candida
| Indication | Status | Phase |
|---|---|---|
| DBCOND0032341 (Vulvovaginal Candidiasis) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT06411314 | Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal Candidiasis | Treatment |